State Street My2034 Corporate Bond ETF
MYCN · ETF
About MYCN
- Issuer
- State Street
- Expense ratio
- 0.15%
- Assets under management
- $9.33M
- Inception
- Sep 24, 2024
- Asset class
- Fixed Income
- Website
- ssga.com
MYCN key statistics
- Price-earnings ratio
- 0.00
- Average volume
- 565
- Volume
- 8
- Open price
- $23.48
- High today
- $23.48
- Low today
- $23.48
- 52 Week high
- $25.20
- 52 Week low
- $23.04
State Street My2034 Corporate Bond ETF (MYCN) at a glance
State Street My2034 Corporate Bond ETF (MYCN) last traded at $23.48, with a price-to-earnings ratio of 0.00.
Volume so far is 8 shares, below the average of 565 shares a day.
Over the past year State Street My2034 Corporate Bond ETF has ranged from $23.04 to $25.20, and now sits 20% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.